methotrexate
Showing 51 - 75 of 944
Acute GVH Disease Trial in Beijing (Methotrexate)
Recruiting
- Acute GVH Disease
- Methotrexate
-
Beijing, Beijing, ChinaPeking University Institute of Hematology,Beijing
Sep 14, 2021
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)
Not yet recruiting
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Venetoclax
- +16 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 23, 2022
Plaque Psoriasis Trial in Outram Park (secukinumab, Methotrexate, Cyclosporin A)
Not yet recruiting
- Plaque Psoriasis
- secukinumab
- +3 more
-
Outram Park, SingaporeSingapore General Hospital
Nov 23, 2022
Plaque Psoriasis Trial in Outram Park (Ixekizumab, Methotrexate, Cyclosporin A)
Recruiting
- Plaque Psoriasis
- Ixekizumab
- +3 more
-
Outram Park, SingaporeSingapore General Hospital
Nov 23, 2022
Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)
Recruiting
- Acute Lymphoid Leukemia
- +3 more
- Prednisone
- +9 more
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Jul 24, 2023
Mind and Skin - the Neurocutaneous Axis in Atopic Eczema
Recruiting
- Atopic Dermatitis
- Methotrexate
-
London, United KingdomUnit for Paediatric and Population-based Dermatology Research
Mar 16, 2023
Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,
Recruiting
- Stage II Bladder Cancer AJCC v8
- +2 more
- Cisplatin
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022
Allogeneic Disease, GVH - Graft Versus Host Reaction, GVHD, Acute Trial in Paris (Methotrexate, Placebo)
Recruiting
- Allogeneic Disease
- +3 more
- Methotrexate
- Placebo
-
Paris, FranceSaint Antoine Hospital - Hematology Department
Oct 22, 2021
Rheumatoid Arthritis, DMARD-naive and Early Disease Patients Trial in Prague (CR6086, Methotrexate, Placebo)
Completed
- Rheumatoid Arthritis, DMARD-naive and Early Disease Patients
- CR6086
- +2 more
-
Prague, CzechiaInstitute of Rheumatology
Oct 4, 2021
Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)
Active, not recruiting
- Hematologic Malignancy
- Tacrolimus
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital
Jan 31, 2023
Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Methotrexate, Adalimumab Injection)
Recruiting
- Arthritis, Rheumatoid
- Iguratimod
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital
Nov 28, 2022
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Cabozantinib S-malate
- +7 more
- (no location specified)
Jan 4, 2023
Granulomatosis With Polyangiitis Trial in Shanghai (Tofacitinib, Methotrexate)
Recruiting
- Granulomatosis With Polyangiitis
- Tofacitinib
- Methotrexate
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 5, 2021
Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)
Terminated
- Rheumatoid Arthritis
- Methotrexate
- +5 more
-
Pondicherry, IndiaDepartment of Clinical Immunology , Jawaharlal Institute of Post
Jul 25, 2021
Rheumatoid Arthritis (RA) Trial in Korea, Republic of (tacrolimus, methotrexate, adalimumab)
Completed
- Rheumatoid Arthritis (RA)
- tacrolimus
- +4 more
-
Daegu, Korea, Republic of
- +9 more
Aug 26, 2021
Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)
Recruiting
- Metastatic Colorectal Cancer
- Alectinib
- +16 more
-
Oslo, NorwayOslo University Hospital
Feb 10, 2023
Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)
Not yet recruiting
- Leukemia
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Dec 23, 2022
Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)
Not yet recruiting
- Mucopolysaccharidosis (MPS)
- Hunter Syndrome
- ELAPRASE
- +3 more
- (no location specified)
Aug 8, 2022
Pediatric Crohn's Disease Trial in United States (Methotrexate, Sugar pill ())
Completed
- Pediatric Crohn's Disease
- Methotrexate
- Sugar pill (placebo)
-
Birmingham, Alabama
- +31 more
Jun 21, 2022
Urothelial Carcinoma of the Bladder Trial in Washington, Baltimore, Philadelphia (drug, radiation, procedure)
Active, not recruiting
- Urothelial Carcinoma of the Bladder
- Methotrexate
- +7 more
-
Washington, District of Columbia
- +3 more
Dec 2, 2022
Healthy Volunteers Trial in Berlin (BAY1830839, Placebo, Midazolam)
Completed
- Healthy Volunteers
- BAY1830839
- +3 more
-
Berlin, GermanyCharité Research Organisation GmbH
May 13, 2022
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
Tumor Metastasis Trial run by the NHLBI (methotrexate, Cyclosporin)
Terminated
- Neoplasm Metastasis
- methotrexate
- Cyclosporin
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 8, 2021
Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in
Active, not recruiting
- Stage I Mantle Cell Lymphoma
- +4 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Buffalo, New York
- +1 more
Mar 9, 2022